Breast cancer exhibits high heterogeneity and is clinically categorized into five intrinsic subtypes based on the expression of the estrogen receptor (ER), the progesterone receptor (PR), epidermal growth factor 2 (ERBB2), and the Ki67 proliferation marker protein (MKI67). This evidence concerns the gene ERBB2 and breast cancer.